Surgery Partners Corp (SGRY) - Kapitalizatsiyaning foydaga nisbati

Surgery Partners Group - SGRY emitenti grafik logotipi

Ambulator markazlarda jarrohlik amaliyotlari sonining ortishi Surgery Partners, Inc. (SGRY) daromadlarining o'sishini faol ravishda rag'batlantirmoqda. Biroq, xodimlar xarajatlari va sug'urta qoplash stavkalari marjalarga bosim o'tkazmoqda. Oftalmologiya va ortopediya sohalariga diversifikatsiya qilish risklarni minimallashtiradi. Kompaniyaning foyda ko'rsatkichi biznes qiymati dinamikasini aks ettiradi, bunda -40.10 ko'rsatkichning joriy qiymatini belgilab, bozor narxi va haqiqiy daromad o'rtasidagi muvozanatni aniqlaydi.

Surgery Partners Group - SGRY Narx-foyda koeffitsiyenti (davr: 04.07.2022 - 11.11.2026)

Surgery Partners Corp (SGRY) kompaniyasining tahliliy kesimlari

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning har tomonlama tahlili:surgerypartners.com - SGRY
Surgery Partners Corp ishlab chiqargan mahsulot

Surgery Partners, Inc. (SGRY) kompaniyasining bozor shoklariga chidamliligi ixtisoslashtirilgan markaz xizmatlariga bo'lgan elastik bo'lmagan talab va sug'urta kompaniyalari bilan kuchli savdolashish imkoniyati bilan ta'minlanadi. Investitsiyalarning qoplanish muddatini aks ettiruvchi bozor kapitalizatsiyasining sof foydaga nisbati, shishgan kutuvlar cho'qqilari paytida haddan tashqari ko'p to'lov qilishdan qochish uchun kompaniyaning P/E tebranishlari orqali aktivning adolatli baholash diapazonini aniqlash imkonini beradi.

Muhim raqobatchilar

Narx-foyda koeffitsiyenti HCA Holdings (HCA)|P/E multiplikatori THC|FMS - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Solventum Inc. SOLV|EHC: Narx-foyda multiplikatori|UHS: Narx-foyda koeffitsiyenti|davita.com - Bozor narxining sof foydaga nisbati|RadNet (RDNT) - Narxning foydaga nisbati|OPCH - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti PINC|P/E multiplikatori America's Best Contacts & Eyeglasses|Narxning foydaga nisbati Progyny, Inc. (PGNY)|ARDT (ardenthealth.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori SEM (Select Medical Holdings)|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Astrana Health Inc|Pediatrix Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati U.S. Physical Therapy|The Pennant Group, Inc. (PNTG) - Narxning foydaga nisbati|organogenesis.com - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti NUTX|Kapitalizatsiyaning foydaga nisbati Auna S.A. AUNA|Narx-foyda koeffitsiyenti SBC (SBC Medical Corp)|EOLS (Evolus Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Community Health Systems CYH|SKIN (The Beauty Health Company) - Kapitalizatsiyaning sof foydaga nisbati|MediWound, Ltd. - P/E multiplikatori|BTMD - P/E multiplikatori|The Joint Corporation (JYNT) - Narxning foydaga nisbati|DocGo, Inc - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti PIII|GANX (gaintherapeutics.com) - Bozor narxining sof foydaga nisbati|Narxning foydaga nisbati EUDA Health Holdings Limited (EUDA)|baselmedical.com - Narx-foyda multiplikatori|P/E multiplikatori CLGN (CollPlant Biotechnologies Ltd.)|Cuprina Holdings Limited (CUPR) - Kapitalizatsiyaning foydaga nisbati|CCM - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati AMS (ashs.com)|MEDIROM Healthcare Group (MRM) - Narxning foydaga nisbati|ALBT - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti DHAI|XAGE: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori NIVF|Biznesning o‘zini qoplash muddati atipt.com|Narxning foydaga nisbati CareMax CMAX|KDLY: Narx-foyda multiplikatori|LogistiCare - P/E multiplikatori|Novo Integrated Sciences Corp (NVOS) - Narx-foyda koeffitsiyenti|SSY (sunlinkhealth.com) - Narx-foyda koeffitsiyenti|BACK - Biznesning o‘zini qoplash muddati